Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Texas Oil Well Drilled

16 Apr 2012 07:00

RNS Number : 3551B
ViaLogy PLC
16 April 2012
 



SUCCESSFUL TEXAS OIL WELL DRILLED

USING VIALOGY ANALYSIS

 

London, Monday, April 16 2012 - ViaLogy PLC (LSE: VIY) announces today that its client Atascosa Exploration of San Antonio has successfully drilled another oil well at the Galba Field in South Central Texas using analysis provided by ViaLogy technology. This is the third commercially successful well Atascosa has drilled in the area using the new technology's recommended co-ordinates.

Under a 2009 contract with Atascosa, ViaLogy had mapped hydrocarbon reservoirs in the three upper Wilcox sandstone formations and provided multiple drilling locations targeting sands at varying depths in the field. Atascosa selected and drilled the new well in the Bartosh formation from its backlog of ViaLogy drilling locations. Oil was found at 3040 feet depth and with the predicted porosity values. Logging and sidewell core analyses have confirmed ViaLogy's predictive analysis and its determination of coordinates for the drilling site. Independent contractor Weatherford's core analysis showed 12 contiguous feet of net oil pay. Significantly, reservoir features were determined below the resolution of the 3-D seismic data using ViaLogy's processing which broadens the useable seismic spectra for both low and high frequencies by extracting and exploiting weak signal data normally discarded as noise.

Under its contract with Atascosa, ViaLogy will receive a 5% Back-In-After-Payout (BIAPO) working interest. This means that the Royalty will be paid on the net amount after drilling and production expenses have been covered.

Commenting on this latest well success Atascosa's Chief Executive, John Mullins, said: "We're very pleased with this drilling and its confirmation of ViaLogy predictions. Based on their recommendations we have increased our lease positions at the prospect. The accuracy of the predictions enabled us to secure approvals from the Texas Railroad Commission (TRRC) to drill additional offset wells at 10 acre spacings. This helps to maximise recovery, and to depart from the TRRC standard field rules that mandate 40 acre spacing between wells. It also ensures we get the best possible financial value from our leases."

 ViaLogy CEO Robert Dean said, "Atascosa was an early adopter of our technology and has been a great partner for us. Together we have been focused on discovering pockets of porosity and hydrocarbon in turbidites and sandstone laminates that are heavily faulted and compartmentalized. While hydrocarbon deposits in these areas may be small by supermajor standards, they are complex and similar in many respects to the much larger fields we are working in now. What's also really important is that they have given us the opportunity to exercise and stress our technology to find hydrocarbon reservoirs below the vertical resolution of 3-D seismic. QuantumRD's capability to characterize such hard-to-image formations and complex stratigraphy is something that is central to our current onshore and offshore projects with the large firms."

Robert Dean added, "We have made good progress in our discussions on new commercial services contracts for QuantumRD with O&G majors and should be able soon to comment publicly."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Katie Ratner, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner/David Banks, Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLLLFEDSIIELIF
Date   Source Headline
1st Aug 202310:32 amRNSForm 8.3 - Yourgene Health PLC
1st Aug 20239:23 amRNSForm 8.5 (EPT/RI)
31st Jul 202310:59 amRNSForm 8.3 - Yourgene Health PLC
31st Jul 20239:38 amRNSForm 8.5 (EPT/RI)
28th Jul 202310:53 amRNSForm 8.5 (EPT/RI)
27th Jul 20237:00 amRNSPublication of Scheme Document & current trading
26th Jul 20234:45 pmRNSForm 8.3 - Yourgene Health plc
26th Jul 202310:12 amRNSForm 8.5 (EPT/RI)
26th Jul 20238:45 amRNSForm 8.3 - YOURGENE HEALTH PLC
26th Jul 20237:00 amRNSFive-year contract extension with Illumina
25th Jul 20232:06 pmRNSForm 8.3 - Yourgene Health plc
25th Jul 20239:48 amRNSForm 8.5 (EPT/RI) - Yourgene Health PLC
25th Jul 20237:00 amRNSForm 8.3 - Yourgene Health Plc
24th Jul 20238:32 amRNSForm 8.3 - Yourgene Health PLC
21st Jul 20238:59 amRNSForm 8.5 (EPT/RI)
20th Jul 202311:44 amRNSForm 8.5 (EPT/RI)
19th Jul 20232:06 pmRNSForm 8.3 - Yourgene Health plc
19th Jul 202312:21 pmRNSRule 2.9 Announcement
19th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
19th Jul 20237:00 amRNSIssue of equity, cancellation of warrants & TVR
18th Jul 20235:15 pmRNSForm 8.5 (EPT/RI) Replacement - Yourgene Health PL
18th Jul 20235:13 pmRNSForm 8.3 - YourGene Health plc
18th Jul 20235:00 pmRNSForm 8.5 (EPT/RI) Replacement
18th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
18th Jul 20238:39 amRNSForm 8.3 - Yourgene Health PLC
17th Jul 20235:00 pmRNSForm 8.3 - Yourgene Health Plc
17th Jul 202312:00 pmRNSForm 8.5 (EPT/RI)
17th Jul 202310:27 amRNSForm 8.5 (EPT/RI)
17th Jul 20239:05 amRNSForm 8.3 - Yourgene Health PLC
17th Jul 20238:15 amRNSForm 8.3 - YOURGENE HEALTH PLC
14th Jul 20232:02 pmRNSForm 8.3 - Yourgene Health plc
14th Jul 202312:02 pmRNSForm 8.5 (EPT/RI)
14th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
14th Jul 202310:36 amRNSForm 8.3 - YOURGENE HEALTH PLC
13th Jul 20235:02 pmRNSForm 8.3 - Yourgene Health PLC - Correction
13th Jul 20234:29 pmRNSForm 8 (OPD) (Yourgene Health Plc)
13th Jul 20232:03 pmRNSForm 8.3 - Yourgene Health plc
13th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
13th Jul 202310:43 amRNSForm 8.3 - Yourgene Health Plc
13th Jul 202310:17 amRNSForm 8.5 (EPT/RI)
13th Jul 20239:02 amRNSForm 8.3 - Yourgene Health PLC
13th Jul 20238:53 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20232:04 pmRNSForm 8.3 - Yourgene Health plc
12th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
12th Jul 202311:39 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20239:21 amRNSForm 8.5 (EPT/RI)
12th Jul 20238:44 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20238:18 amRNSForm 8.3 - Yourgene Health PLC
11th Jul 20232:20 pmRNSForm 8.3 - Yourgene Health plc
11th Jul 202312:46 pmRNSForm 8.3 - Yourgene Health PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.